FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/02/104231 [Registered on: 18/02/2026] Trial Registered Prospectively
Last Modified On: 18/02/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A study on efficacy of Kulattha ghana vati in Mutrashmari (Urolithiasis) f0r age group of 25-50 years, for 30 days 
Scientific Title of Study   Efficacy of Kulattha ghana vati in comparison to Gokshuradi guggulu in Mutrashmari-Urolithiasis - A Randomised clinical study  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Soundarya Shrishail Biradar  
Designation  Post Graduation scholar, Department of Shalya Tantra 
Affiliation  Sri Dharmasthala manjunatheshwara institute of Ayurveda and Hospital, Anchepalya, Kumbalagodu post , Bangalore 
Address  Sri Dharmasthala Manjunatheswara institute of Ayurveda and Hospital, Bengaluru, Karnataka 560074

Bangalore
KARNATAKA
560074
India 
Phone  9743191707  
Fax    
Email  soundaryabiradar1999@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Bharati D Anvekar 
Designation  Professor, Department of Shalya Tantra  
Affiliation  Sri Dharmasthala manjunatheshwara institute of Ayurveda and Hospital, Anchepalya, Kumbalagodu post, Bangalore 
Address  Sri Dharmasthala Manjunatheswara institute of Ayurveda and Hospital, Bengaluru, Karnataka 560074

Bangalore
KARNATAKA
560074
India 
Phone  9886410690  
Fax    
Email  bharathisanjeev@sdmayurbangalore.in  
 
Details of Contact Person
Public Query
 
Name  Dr Soundarya Shrishail Biradar  
Designation  Post Graduation scholar, Department of Shalya Tantra 
Affiliation  Sri Dharmasthala manjunatheshwara Institute of Ayurveda and Hospital, Anchepalya, Kumbalagodu post , Bangalore 
Address  Sri Dharmasthala Manjunatheswara institute of Ayurveda and Hospital, Bengaluru, Karnataka 560074

Bangalore
KARNATAKA
560074
India 
Phone  9743191707  
Fax    
Email  soundaryabiradar1999@gmail.com  
 
Source of Monetary or Material Support  
Shri Dharmasthala Manjunatheshwara Institute of Ayurveda and Hospital, Anchepalya, Kumbalagodu post, Bangalore- 560074, Karnataka, India 
 
Primary Sponsor  
Name  Dr Soundarya Shrishail Biradar 
Address  Shri Dharmasthala Manjunatheshwara Institute of Ayurveda and Hospital, Anchepalya, Kumbalagodu post, Bangalore- 560074, Karnataka, India 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
Nil  Nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Soundarya Shrishail Biradar  Shri Dharmasthala Manjunatheshwara Institute of Ayurveda and Hospital, Bangalore  Department of Shalya Tantra, OPD number - 16,18,19,20,21
Bangalore
KARNATAKA 
9743191707

soundaryabiradar1999@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional ethics committee Sri Dharmasthala Manjunatheshwara Institute of Ayurveda and Hospital, Anchepalya, Kumbalagodu Post, Bangalore - 560074, Karnataka, India  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N21||Calculus of lower urinary tract. Ayurveda Condition: MUTRAVAHASROTOVIKARAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Kulattha ghana vati, Reference: Bhavaprakasha nighantu, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 30 Days, anupAna/sahapAna: Yes(details: -jala), Additional Information: -
2Comparator ArmDrugClassical(1) Medicine Name: Gokshuradi guggulu, Reference: Ayurveda formulary of India, Route: Oral, Dosage Form: Guggulu , Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 30 Days, anupAna/sahapAna: Yes(details: -Jala), Additional Information: -
 
Inclusion Criteria  
Age From  25.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  1)Asymptomatic subjects who will be diagnosed with urolithiasis, detected accidentally by
USG of Abdomen and pelvis. 2) Irrespective of gender, Socioeconomic status, religion and place. 3) Subjects aged between 25 - 50 yrs. 4) Subjects with solitary or multiple calculi. 5) Stone location - Kidney, ureter and bladder. 6) Size of stone within 10 days 
 
ExclusionCriteria 
Details  1) Subjects suffering from Chronic kidney diseases. 2) Pregnant and Lactating mother. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
1. Reduction in the size of Mutrashmari.  0th day(baseline), 15th day and 30 day 
 
Secondary Outcome  
Outcome  TimePoints 
Reduction in the Symptoms of patients like pain in abdomen /flank, haemeturia, Dysuria , UTIs  0th day(baseline), 15th day & 30th day 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   01/03/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="7" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   A randomised clinical study on the efficacy of Kulattha ghana vati in Mutrashmari (Urolithiasis) in age group of 25 to 50 years for a period of 30 days. During this study period 30 subjects diagnosed with Mutrashmari (Urolithiasis) will be recruited and divided into two groups, Group A (Trial drug / Intervention drug) and Group B (Control drug / Comparator drug) 15 subjects in each group respectively.
Group A includes 15 subjects qualifying inclusion criteria of the current study will be administered Kulattha ghana vati internaly in the dose of 500 mg twice a day before food followed by jalapana and assessment of the patient during trial on 0th day, 15th day and 30th day. Group B includes 15 subjects qualifying inclusion criteria of the current study will be administered Gokshuradi guggulu internaly in the dose of 500 mg twice a day before food followed by jalapana and assessment of the patient during trial on 0th day, 15th day and 30th day. The outcome measures will be significant improvement noticed in Mutrashmari (Urolithiasis) after 30 days. Statistical analysis will be done through data obtained based on before and after treatment assessment.
 
Close